Faster Launch, Increased Adoption, Higher Revenue, and a Playbook for Commercial Success. Read the white paper.
Download Now
Skip to content
prognos-logo-light Prognos Health
Main Menu
  • Support
  • Client Login
  • Request Demo
  • Prognos Factor®
    • Marketplace
      • Explore & Buy Data
      • Become a Data Provider
  • Products
    • Life Sciences
      • Cohort Designer
      • Patient Journey Software
      • Physician Segmentation
      • Outcomes Insights
      • Alerts
      • Omnichannel Marketing
    • Payers
      • Underwriting Risk Predictor
  • Company
    • Careers
    • News
    • Insights
    • Resources
  • Contact Us
Home Insights Plan, Activate, and Optimize Precision HCP Marketing

Plan, Activate, and Optimize Precision HCP Marketing

  • April 25, 2022
  • Posted in Alerts
precision hcp marketing

Without the proper support to know how, when, and where to reach HCPs, it can be challenging to achieve commercialization goals. Luckily, end-to-end solutions such as the Prognos Factor RWD analytics platform work to streamline and support precision marketing efforts across the entire patient journey. 

Using our suite of solutions, pharma companies can utilize RWD to methodically and precisely target HCPs at the top of the funnel to drive brand awareness through the bottom of the funnel, intercepting them ahead of a treatment decision.

Prognos’ platform enables pharma companies to use RWD to plan, activate, and optimize their commercialization strategy. Here’s how:

PLAN

Pharma companies can strategically plan their commercialization efforts using RWD and analytics pulled from the Prognos platform that uses precise alerts for healthcare marketing to target HCPs. 

First, companies identify the proper patient populations with precision targeting. Then, they can create a customized communication strategy centered around alerts that trigger throughout the patient journey for precision outreach and meaningful engagement. They can also leverage omnichannel marketing to plan the best way to reach providers. 

ACTIVATE

After a robust plan is established, pharma companies can activate, executing the tactics to drive disease and brand awareness, and acquisition and retention efforts.

During the activation stage, users can leverage Prognos’ RWD data platform to:

  • Segment HCPs: Pinpoint the target HCPs treating specific conditions. 
  • Sequenced Alerts: Alerts trigger when events occur throughout the patient journey informing the field of appropriate times for outreach (newly tested, diagnosed, therapy starts).
  • Send Personalized Messages: Keeping your brand top of mind with HCP outreach. 
  • Upper funnel: Prime HCPs and build awareness & affinity with their brand and field rep before patient events occur.
  • Lower funnel:  Because of proactive alerts and insights throughout the journey, reps can intervene at precise moments and stay ahead of treatment decisions.

OPTIMIZE

Once a plan is activated, now it is time to refine and measure to optimize their precision marketing program. Prognos’ platform automatically maps and customizes essential metrics to monitor and measure outcomes. 

For example: If a company is interested in measuring Rx script volume, after planning and activating real-time segmentation schemes, Prognos can analyze this program and determine who went on therapies and when delivering actionable metrics.

This type of in-depth and custom analysis gives pharma companies the visibility they need to enhance their strategy by:

  • Measuring the impact the brand has had against its goals. 
  • Determining what specific area of the marketing program requires optimization.
  • Understanding which channels/modes of outreach are most effective.
  • Refining segmentation schemes and alerting triggers for strategic alignment.

Want to see Prognos Factor in action?

Our precision marketing is modular, giving you the flexibility to tailor and customize it to best suit your brand and organization’s needs.

See how Prognos Factor can help your company reach its unique marketing goals across the entire patient journey by requesting a personalized demo.

« How to use RWD for provider engagement: 3 pharma best practices
How RWD Marketplaces Help Solve Pharma’s Top 10 Challenges to Gathering Actionable Data »

Categories

  • AI
  • Alerts
  • Clinical
  • Commercial Launch Excellence
  • Disease Awareness
  • Lab Testing Insights
  • Lab Testing Trends
  • Marketplace
  • Omnichannel Marketing
  • Patient Journey
  • Physician Segmentation
  • Prog Spotlight
  • RWD
  • Technology
  • Underwriting

Archives

Latest Tweets

Prognos HealthFollow

Query billions of fully-integrated lab & health records on more than 325M de-identified patients to answer key healthcare questions in minutes on prognosFACTOR.

Prognos Health
prognosAIPrognos Health@prognosAI·
12 Apr

In our recent panel discussion “How to determine your next best action for every HCP engagement”, leaders from Novartis, GSK, and Takeda Oncology discussed their #RWD strategies to commercialize drug therapies. 3 important best practices were revealed. https://prognoshealth.com/blog/provider-engagement/?utm_source=twitter&utm_medium=social&utm_campaign=provider_engagement_blog

Reply on Twitter 1513876896056057856Retweet on Twitter 1513876896056057856Like on Twitter 1513876896056057856Twitter 1513876896056057856
prognosAIPrognos Health@prognosAI·
7 Apr

68% of #pharma leaders believe the way #lifescience companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help address them.

https://prognoshealth.com/blog/real-world-data-pharma-paradigm-shift/?utm_source=twitter&utm_medium=social&utm_campaign=rwd_paradigm_shift_blog

#RealWorldData

Reply on Twitter 1512114401360461827Retweet on Twitter 15121144013604618271Like on Twitter 1512114401360461827Twitter 1512114401360461827
prognosAIPrognos Health@prognosAI·
5 Apr

Therapy-related #RWD insights and learnings for a new brand launch can take 12-18 months. One leading #pharma company cut this time in half. Find out how.
https://prognoshealth.com/resource/rwd-analysis/?utm_source=twitter&utm_medium=social&utm_campaign=oncology_case_study

#Omnichannel #Oncology #Pharmaceutical #TherapyLaunch #RealWorldData

Reply on Twitter 1511355425660325897Retweet on Twitter 15113554256603258971Like on Twitter 15113554256603258971Twitter 1511355425660325897
prognosAIPrognos Health@prognosAI·
3 Mar

In a recent survey of #pharma leaders by Reuters, 68% of respondents believe the way #LifeSciences companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help.

https://prognoshealth.com/blog/real-world-data-pharma-paradigm-shift/?utm_source=twitter&utm_medium=social&utm_campaign=real_world_data_in_pharma_paradigm_shift

Reply on Twitter 1499488030222168066Retweet on Twitter 14994880302221680661Like on Twitter 1499488030222168066Twitter 1499488030222168066
prognosAIPrognos Health@prognosAI·
1 Mar

Dr. Steven Zatz Joins Prognos Health Board of Directors

"Steve’s vision and leadership helped build WebMD into an iconic healthcare brand," says @sundeepbhan1.

https://prognoshealth.com/about-us/news/press-release/dr-steven-zatz-joins-prognos-health-board-of-directors/?utm_source=twitter&utm_medium=social&utm_campaign=dr_zatz_joins_board

Reply on Twitter 1498679196536737795Retweet on Twitter 14986791965367377951Like on Twitter 14986791965367377951Twitter 1498679196536737795
Load More...
  • Prognos Factor®
    • Prognos Marketplace
  • Products
    • Life Sciences
    • Payers
  • Company
    • Insights
    • Careers
    • News
  • LinkedIn
  • Twitter
  • YouTube
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Site Map
© Prognos Health, 2022. All Rights Reserved.

Get Answers Faster

Watch your questions answered with unparalleled speed. De-identified record level patient data already integrated & easily linked to other sources. Prognos puts you in control.

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. For more details about cookies and their use, please see our Privacy Policy.